May 30, 2012
1 min read
Save

Better pediatric Lyme meningitis treatments needed

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Current Lyme meningitis treatment regimens have substantial associated morbidity, according to study results from researchers at the Nemours/Alfred I. duPont Hospital for Children in Wilmington, Del.

Perspective from Eugene Shapiro, MD

Amy D. Thompson, MD, and colleagues from the division of emergency conducted a retrospective cohort study of 149 children with a median age of 10 years who presented with Lyme meningitis in one of three EDs in the Lyme-endemic areas of Pennsylvania and Massachusetts between 1997 and 2010. Children were treated with parenteral antibiotics, most commonly ceftriaxone, received through a peripherally inserted central catheter (PICC).

The researchers said children often have complications related to either the PICC or the prescribed antibiotic. According to Thompson and colleagues, 26% of the 149 study participants with follow-up records had one or more complications. Adverse drug reactions occurred in 10% of patients.

They said of the 144 children who had a PICC placed, 17% had at least one PICC-associated complication; 10% had a mechanical problem; 8% had an infectious complication; and 1% had a venous thromboembolism.

“Given the high complication rates, aseptic infusion techniques, stabilization devices, and patient education should be optimized,” the researchers concluded. “Further investigation into alternate treatment regimens including a randomized clinical trial comparing oral doxycycline to parental ceftriaxone is needed.”

Disclosure: Dr. Thompson reports no relevant financial disclosures.